Clinical Scorecard: Serostatus May Modify RA Activity–CV Link

At a Glance

Key Highlights

• Higher rheumatoid arthritis disease activity linked to increased risk of cardiovascular events.
• Each 1-unit increase in DAS28-CRP associated with an 18% higher hazard of cardiovascular events.
• Combined serostatus of RF and ACPA may influence cardiovascular risk assessment.
• 184 patients experienced a first major adverse cardiovascular event during follow-up.
• Caution advised against interpreting low disease activity as low cardiovascular risk.

Guideline-Based Recommendations

Diagnosis

• Assess disease activity using DAS28-CRP.

Management

• Consider serostatus when evaluating cardiovascular risk in rheumatoid arthritis patients.

Monitoring & Follow-up

• Monitor disease activity and cardiovascular risk factors at enrollment.

Risks

• Patients with low disease activity should not be assumed to have low cardiovascular risk.

Patient & Prescribing Data

Patients with rheumatoid arthritis enrolled in the ATACC-RA consortium.

Corticosteroid use and traditional cardiovascular risk factors should be considered in management.

Clinical Best Practices

• Evaluate combined serostatus for cardiovascular risk assessment.
• Use imaging-based risk reclassification in selected serologic groups.

Related Resources & Content

• RMD Open